Subjects with Non-alcoholic Fatty Liver Disease and Severe Fibrosis Face a Significant Number of Adverse Events: Cryptogenic Cirrhosis and Severe Steatofibrosis
Publication
, Conference
Younossi, ZM; Stepanova, M; Harrison, SA; Sanyal, AJ; Ratziu, V; McColgan, BJ; Myers, RP; Subramanian, M; McHutchison, JG; Afdhal, NH; Bosch, J ...
Published in: HEPATOLOGY
October 1, 2017
Published In
HEPATOLOGY
EISSN
1527-3350
ISSN
0270-9139
Publication Date
October 1, 2017
Volume
66
Start / End Page
1154A / 1155A
Location
Washington, DC
Publisher
WILEY
Conference Name
68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics
Citation
APA
Chicago
ICMJE
MLA
NLM
Younossi, Z. M., Stepanova, M., Harrison, S. A., Sanyal, A. J., Ratziu, V., McColgan, B. J., … Goodman, Z. D. (2017). Subjects with Non-alcoholic Fatty Liver Disease and Severe Fibrosis Face a Significant Number of Adverse Events: Cryptogenic Cirrhosis and Severe Steatofibrosis. In HEPATOLOGY (Vol. 66, pp. 1154A-1155A). Washington, DC: WILEY.
Younossi, Zobair M., Maria Stepanova, Stephen A. Harrison, Arun J. Sanyal, Vlad Ratziu, Bryan J. McColgan, Robert P. Myers, et al. “Subjects with Non-alcoholic Fatty Liver Disease and Severe Fibrosis Face a Significant Number of Adverse Events: Cryptogenic Cirrhosis and Severe Steatofibrosis.” In HEPATOLOGY, 66:1154A-1155A. WILEY, 2017.
Younossi ZM, Stepanova M, Harrison SA, Sanyal AJ, Ratziu V, McColgan BJ, et al. Subjects with Non-alcoholic Fatty Liver Disease and Severe Fibrosis Face a Significant Number of Adverse Events: Cryptogenic Cirrhosis and Severe Steatofibrosis. In: HEPATOLOGY. WILEY; 2017. p. 1154A-1155A.
Younossi, Zobair M., et al. “Subjects with Non-alcoholic Fatty Liver Disease and Severe Fibrosis Face a Significant Number of Adverse Events: Cryptogenic Cirrhosis and Severe Steatofibrosis.” HEPATOLOGY, vol. 66, WILEY, 2017, pp. 1154A-1155A.
Younossi ZM, Stepanova M, Harrison SA, Sanyal AJ, Ratziu V, McColgan BJ, Myers RP, Subramanian M, McHutchison JG, Afdhal NH, Abdelmalek MF, Bosch J, Goodman ZD. Subjects with Non-alcoholic Fatty Liver Disease and Severe Fibrosis Face a Significant Number of Adverse Events: Cryptogenic Cirrhosis and Severe Steatofibrosis. HEPATOLOGY. WILEY; 2017. p. 1154A-1155A.
Published In
HEPATOLOGY
EISSN
1527-3350
ISSN
0270-9139
Publication Date
October 1, 2017
Volume
66
Start / End Page
1154A / 1155A
Location
Washington, DC
Publisher
WILEY
Conference Name
68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics